COVID-19-associated fungal infections

M Hoenigl, D Seidel, R Sprute, C Cunha… - Nature …, 2022 - nature.com
Abstract Coronavirus disease 2019 (COVID-19)-associated invasive fungal infections are an
important complication in a substantial number of critically ill, hospitalized patients with …

A visual and comprehensive review on COVID-19-associated pulmonary aspergillosis (CAPA)

S Feys, MP Almyroudi, R Braspenning, K Lagrou… - Journal of Fungi, 2021 - mdpi.com
Coronavirus disease 19 (COVID-19)-associated pulmonary aspergillosis (CAPA) is a severe
fungal infection complicating critically ill COVID-19 patients. Numerous retrospective and …

[HTML][HTML] Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients—a multinational observational study by the European …

J Prattes, J Wauters, DR Giacobbe… - Clinical Microbiology …, 2022 - Elsevier
Abstract Objectives Coronavirus disease 2019 (COVID-19)-associated pulmonary
aspergillosis (CAPA) has emerged as a complication in critically ill COVID-19 patients. The …

Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis

PE Verweij, RJM Brüggemann, E Azoulay… - Intensive care …, 2021 - Springer
Purpose Invasive pulmonary aspergillosis (IPA) is increasingly reported in patients with
severe coronavirus disease 2019 (COVID-19) admitted to the intensive care unit (ICU) …

Coronavirus disease 2019–associated invasive fungal infection

JW Baddley, GR Thompson III… - Open forum …, 2021 - academic.oup.com
Abstract Coronavirus disease 2019 (COVID-19) can become complicated by secondary
invasive fungal infections (IFIs), stemming primarily from severe lung damage and …

Fungal infections in mechanically ventilated patients with COVID-19 during the first wave: the French multicentre MYCOVID study

JP Gangneux, E Dannaoui, A Fekkar… - The Lancet …, 2022 - thelancet.com
Background Patients with severe COVID-19 have emerged as a population at high risk of
invasive fungal infections (IFIs). However, to our knowledge, the prevalence of IFIs has not …

Incidence and mortality of COVID‐19‐associated pulmonary aspergillosis: a systematic review and meta‐analysis

H Mitaka, T Kuno, H Takagi, P Patrawalla - Mycoses, 2021 - Wiley Online Library
Abstract COVID‐19‐associated pulmonary aspergillosis (CAPA) has been reported
worldwide. However, basic epidemiological characteristics have not been well established …

Invasive pulmonary aspergillosis among intubated patients with SARS-CoV-2 or influenza pneumonia: a European multicenter comparative cohort study

A Rouzé, E Lemaitre, I Martin-Loeches, P Povoa… - Critical Care, 2022 - Springer
Background Recent multicenter studies identified COVID-19 as a risk factor for invasive
pulmonary aspergillosis (IPA). However, no large multicenter study has compared the …

Corticosteroids as risk factor for COVID-19-associated pulmonary aspergillosis in intensive care patients

R Leistner, L Schroeter, T Adam, D Poddubnyy… - Critical Care, 2022 - Springer
Purpose Corticosteroids, in particular dexamethasone, are one of the primary treatment
options for critically ill COVID-19 patients. However, there are a growing number of cases …

Aspergillus test profiles and mortality in critically ill COVID-19 patients

M Ergün, RJM Brüggemann, A Alanio… - Journal of clinical …, 2021 - Am Soc Microbiol
The literature regarding COVID-19-associated pulmonary aspergillosis (CAPA) has shown
conflicting observations, including survival of CAPA patients not receiving antifungal therapy …